CRISPR-Cas9 editing leads to widespread loss of the targeted chromosome in human T cells, but scientists recently discovered a way to prevent such loss.
DNASTAR announced today the release of Lasergene 17.3, which includes new features and functionality focused on genomic analysis and variant identification supporting COVID-19 research.